Skip to content
Economy · Greece
Obesity program 'Prolemvano' faces delays due to 44% retroactive clawbacks from pharmaceutical companies
2 sourcesFirst reported 2 hours agoUpdated 21 minutes ago
AI summary: catch up in 20 seconds
Summarising the coverage…
Generated by AI from the 2 sources below · always verify with the originals
Comments · 0 (subscribers)
Sign in to join the discussion.
No comments yet. Be the first to join the discussion.